Trial Profile
A Single Dose Study to Evaluate the Effect of BMS-986120 on Thrombus Formation in an Ex Vivo Thrombosis Chamber Model in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Feb 2019
Price :
$35
*
At a glance
- Drugs BMS 986120 (Primary) ; Aspirin; Clopidogrel
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms PROBE
- Sponsors Bristol-Myers Squibb
- 18 Mar 2017 Results (n=20) presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 16 Nov 2016 Results assessing efficacy of BMS-986120, presented at the 89th Annual Scientific Sessions of the American Heart Association
- 07 Apr 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.